Home › Funds › Mubadala Investment Co PJSC › GILD
Mubadala Investment Co PJSC position in GILD
GILEAD SCIENCES INC · Health Care
Mubadala Investment Co PJSC reported holding 29,623 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$3.7M, representing 0.01% of its reported portfolio and ranking #49 among its reported holdings. Mubadala Investment Co PJSC has disclosed GILD holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Mubadala Investment Co PJSC's GILD position evolved
Mubadala Investment Co PJSC first disclosed a stake in GILD in Q4 2024 at 43,908 shares (US$4.1M). The position peaked in Q4 2025 at 100,178 shares, worth US$12.3M. Across 7 filings, Mubadala Investment Co PJSC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 29,623 shares valued at US$3.7M — a reduction of -7,370 shares quarter over quarter.. Notable position changes include a 69% increase in Q2 2025 (shares were roughly flat over the following quarter), a 30% increase in Q4 2025 (shares rose 14% over the following quarter), a 63% trim in Q1 2026 (shares fell 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 43.91K | $4.06M | New |
| Q1 2025 | 42.75K | $4.79M | Reduce |
| Q2 2025 | 72.28K | $8.01M | Add |
| Q3 2025 | 76.84K | $8.53M | Add |
| Q4 2025 | 100.18K | $12.30M | Add |
| Q1 2026 | 36.99K | $5.16M | Reduce |
| Q2 2026 | 29.62K | $3.74M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on Mubadala Investment Co PJSC
FAQ
How long has Mubadala Investment Co PJSC held GILD?
Mubadala Investment Co PJSC has disclosed GILD holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Mubadala Investment Co PJSC's current position in GILD?
As of Q2 2026, Mubadala Investment Co PJSC holds 29.62K shares of GILD (GILEAD SCIENCES INC), valued at $3.74M, representing 0.01% of its reported portfolio and ranking #49.
Has Mubadala Investment Co PJSC been buying or selling GILD?
In the latest 13F filing (Q2 2026), Mubadala Investment Co PJSC reduced its position in GILD. The position peaked in Q4 2025 at 100.18K shares.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.